MedPath

The efficacy of Traditional Japanese Medicine"keishikasyakuyakuto" for irritable bowel syndrome:A multi-center, double-blinded, placebo-controlled, randomized trial

Phase 2
Conditions
irritable bowel syndrome
Registration Number
JPRN-UMIN000026235
Lead Sponsor
Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1, Patients who had history of gastrointestinal tract resection 2, Patients who have severe complications 3, Patients who have history or current evidence of celiac disease or inflammatory bowel disease 4, Patients who under treatment with steroid or biological products 5, Patients who have severe psychiatric disease 6, Patients who have current evidence of abuse of drugs or alcohol 7, Patients who have history of Kampo allergies 8, Patients who had taken new drug therapy within 4 weeks before entry 10, Patients who had any change in types, dosage,or adiministration of their prescribed drugs within 4 weeks before entry 11, Patients who or are going to take new medicines 12, Patients who have been enrolled in previous clinical trials of Keishikashakuyakuto or have taken Keishikashakuyakuto before entry this trial 13, Patients who or are going to be participating in other clinical studies 14, Patients who are pregnant or possibly pregnant 15, Patients who are lactating 16, Patients who are judged as inadequately for study entry

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The comparison of the change in IBS-QOL overall score from pre-to posttreatment among two groups
Secondary Outcome Measures
NameTimeMethod
1,The comparison of the change in IBS-QOL overall score from pre-to after 4 weeks of treatment among two groups 2,The comparison of the changes in IBS-QOL score of 8 subscales from pre-to posttreatment among two groups 3,The comparison of the change in IBS-QOL overall score from pre-to posttreatment by 4 subtypes of IBS among two groups 4,The comparison of the change in IBS-SI score from pre-to posttreatment among two groups
© Copyright 2025. All Rights Reserved by MedPath